Alembic Limited (IN:ALEMBICLTD)
:ALEMBICLTD
Want to see IN:ALEMBICLTD full AI Analyst Report?
ALEMBICLTD Stock Chart & Stats
₹103.40
-₹1.48(-1.12%)
At close: 4:00 PM EST
₹103.40
-₹1.48(-1.12%)
Day’s Range― - ―
52-Week Range₹70.64 - ₹125.70
Previous CloseN/A
Volume165.88K
Average Volume (3M)22.23K
Market Cap
₹22.53B
Enterprise Value₹22.54B
Total Cash (Recent Filing)₹888.10M
Total Debt (Recent Filing)₹125.80M
Price to Earnings (P/E)5.7
Beta1.45
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.36%
Share Statistics
EPS (TTM)12.62
Shares Outstanding256,781,830
10 Day Avg. Volume15,327
30 Day Avg. Volume22,227
Financial Highlights & Ratios
PEG Ratio2.67
Price to Book (P/B)0.74
Price to Sales (P/S)7.59
P/FCF Ratio17.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetAlembic's minimal net debt and stable asset base provide durable financial flexibility. Low leverage reduces solvency risk, supports sustained R&D and capex funding, and makes the company better able to weather industry cycles or absorb one-off shocks without eroding core operations.
Diversified Pharma ModelThe firm's combination of branded formulations, generic/export markets and API manufacturing creates multiple revenue channels. Manufacturing scale plus R&D and a domestic sales/distribution franchise support resilience versus single-product risk and help sustain medium-term revenue generation.
Steady Revenue Growth & Improving CashA multi-year top-line increase combined with a material step-up in operating cash flow to 1.82B indicates improving core cash generation. This enhances capacity to reinvest in new filings, support commercial expansion and maintain payouts without relying on external financing.
Bears Say
Earnings Quality ConcernsReported net income being unusually high relative to revenue suggests material non-operating gains or accounting effects. That reduces the reliability of reported earnings as a guide to recurring operating profitability and complicates forecasting of sustainable cash flows and returns.
Weakened Operating ProfitabilityThe notable decline in EBITDA and EBIT year-over-year points to margin pressure or adverse mix/cost dynamics. Sustained erosion of operating profits would impair internal funding for R&D and manufacturing, and could materially lower long-term free cash generation if not arrested.
Volatile Cash Flow HistoryPast periods of negative OCF and swings in free cash flow indicate working-capital and collection timing risks. Even with recent improvement, this volatility undermines predictability for capital allocation, making sustained investment or dividend policies more uncertain.
Alembic Limited News
ALEMBICLTD FAQ
What was Alembic Limited’s price range in the past 12 months?
Alembic Limited lowest stock price was ₹70.64 and its highest was ₹125.70 in the past 12 months.
What is Alembic Limited’s market cap?
Alembic Limited’s market cap is ₹22.53B.
When is Alembic Limited’s upcoming earnings report date?
Alembic Limited’s upcoming earnings report date is Aug 06, 2026 which is in 71 days.
How were Alembic Limited’s earnings last quarter?
Alembic Limited released its earnings results on May 19, 2026. The company reported ₹2.61 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.61.
Is Alembic Limited overvalued?
According to Wall Street analysts Alembic Limited’s price is currently Overvalued.
Does Alembic Limited pay dividends?
Alembic Limited pays a Annually dividend of ₹2.4 which represents an annual dividend yield of 2.36%. See more information on Alembic Limited dividends here
What is Alembic Limited’s EPS estimate?
Alembic Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alembic Limited have?
Alembic Limited has 256,781,830 shares outstanding.
What happened to Alembic Limited’s price movement after its last earnings report?
Alembic Limited reported an EPS of ₹2.61 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.673%.
Which hedge fund is a major shareholder of Alembic Limited?
Currently, no hedge funds are holding shares in IN:ALEMBICLTD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Alembic Limited
Alembic Limited engages in the manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API). It operates through API and Real Estate segments. The company is also involved in the construction of residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. In addition, it operates co-generation plants with a total capacity of 11 MW; and wind power plants with a total capacity of 5 MW. The company also exports its products. Alembic Limited was founded in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Limited.
Technical Analysis
Alkem Laboratories Ltd.
―
Alembic Pharmaceuticals Limited
―
Aurobindo Pharma Ltd
―
Glenmark Pharmaceuticals Limited
―
IPCA Laboratories Limited
―